USD 0.07
(-5.71%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 452.94 Thousand USD | -3.06% |
2022 | 467.24 Thousand USD | -51.83% |
2021 | 969.99 Thousand USD | 46.62% |
2020 | 661.55 Thousand USD | -59.23% |
2019 | 1.62 Million USD | 64.76% |
2018 | 984.77 Thousand USD | -36.78% |
2017 | 1.55 Million USD | -55.19% |
2016 | 3.47 Million USD | 201.08% |
2015 | 1.15 Million USD | 96117.08% |
2014 | 1200.00 USD | -59.81% |
2013 | 2986.00 USD | 30.62% |
2012 | 2286.00 USD | 286.15% |
2011 | 592.00 USD | 0.0% |
2010 | - USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 173.35 Thousand USD | 43.88% |
2023 Q2 | 158.53 Thousand USD | 109.76% |
2023 Q3 | 98.35 Thousand USD | -37.96% |
2023 FY | 452.94 Thousand USD | -3.06% |
2023 Q4 | 120.48 Thousand USD | 22.51% |
2023 Q1 | 75.57 Thousand USD | -12.82% |
2022 Q2 | 128.14 Thousand USD | 0.65% |
2022 Q4 | 86.69 Thousand USD | -30.69% |
2022 FY | 467.24 Thousand USD | -51.83% |
2022 Q1 | 127.32 Thousand USD | -75.61% |
2022 Q3 | 125.09 Thousand USD | -2.38% |
2021 Q3 | 127.03 Thousand USD | -21.25% |
2021 Q2 | 161.3 Thousand USD | 29.36% |
2021 Q4 | 521.96 Thousand USD | 310.89% |
2021 Q1 | 124.69 Thousand USD | -81.34% |
2021 FY | 969.99 Thousand USD | 46.62% |
2020 Q2 | 199.4 Million USD | 0.73% |
2020 FY | 661.55 Thousand USD | -59.23% |
2020 Q4 | 668.41 Thousand USD | 25.25% |
2020 Q3 | 533.67 Thousand USD | -99.73% |
2020 Q1 | 197.96 Million USD | -14.74% |
2019 Q4 | 232.19 Million USD | 0.0% |
2019 FY | 1.62 Million USD | 64.76% |
2018 FY | 984.77 Thousand USD | -36.78% |
2018 Q4 | 398.63 Thousand USD | 0.0% |
2017 FY | 1.55 Million USD | -55.19% |
2016 FY | 3.47 Million USD | 201.08% |
2015 Q1 | 541.00 USD | 72.29% |
2015 FY | 1.15 Million USD | 96117.08% |
2015 Q3 | 594.12 Thousand USD | 544964.22% |
2015 Q2 | 109.00 USD | -79.85% |
2014 Q2 | -86.00 USD | -110.15% |
2014 Q1 | 847.00 USD | -41.14% |
2014 FY | 1200.00 USD | -59.81% |
2014 Q4 | 314.00 USD | 151.2% |
2014 Q3 | 125.00 USD | 245.35% |
2013 Q1 | 847.00 USD | 0.0% |
2013 FY | 2986.00 USD | 30.62% |
2013 Q4 | 1439.00 USD | 50.68% |
2013 Q3 | 955.00 USD | 474.51% |
2013 Q2 | -255.00 USD | -130.11% |
2012 FY | 2286.00 USD | 286.15% |
2011 FY | 592.00 USD | 0.0% |
2010 FY | - USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alternative Energy Partners, Inc. | 3437.19 USD | -13077.857% |
Allstar Health Brands, Inc. | 215.74 Thousand USD | -109.944% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 55.24 Million USD | 99.18% |
Café Serendipity Holdings, Inc. | 1.43 Million USD | 68.464% |
Decision Diagnostics Corp. | - USD | -Infinity% |
Health Advance Inc. | 47.57 Thousand USD | -852.172% |
HealthWarehouse.com, Inc. | 13.79 Million USD | 96.717% |
LIGAND PHARMACEUTICAL INC | 78.2 Million USD | 99.421% |
MedGen, Inc. | 16.59 USD | -2730147.137% |
Omni Health, Inc. | 1.14 Million USD | 60.511% |
Oxford Investments Holdings Inc. | 373.76 Thousand USD | -21.187% |
ScripsAmerica, Inc. | 31.4 Million USD | 98.558% |